Abstract
In this chapter, we review some common adverse effects seen when treating older adults with psychotropic medications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Balt SL, Galloway GP, Baggott MJ, et al. Mechanisms and genetics of antipsychotic-associated weight gain. Clin Pharmacol Ther. 2011;90(1):179–83.
Chew ML, Mulsant BH, Pollock BG, et al. A model of anticholinergic activity of atypical antipsychotic medications. Schizophr Res. 2006;88(1–3):63–72.
Chew ML, Mulsant BH, Pollock BG, et al. Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc. 2008;56(7):1333–41.
Cohen R, Wilkins KM, Ostroff R, et al. Olanzapine and acute urinary retention in two geriatric patients. Am J Geriatr Pharmacother. 2007;5(3):241–6.
de Leon J, Santoro V, D’Arrigo C, Spina E. Interactions between antiepileptics and second-generation antipsychotics. Expert Opin Drug Metab Toxicol. 2012;8(3):311–34.
Filippatos TD, Makri A, Elisaf MS, Liamis G. Hyponatremia in the elderly: challenges and solutions. Clin Interv Aging. 2017;12:1957–65.
Francis Lam YW. Warfarin and SSRIs. The Brown University Psychopharmacology Update. 2017;28(12):2–3.
Gareri P, Segura-GarcÃa C, Manfredi VG, et al. Use of atypical antipsychotics in the elderly: a clinical review. Clin Interv Aging. 2014;9:1363–73.
Gillman PK. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br J Pharmacol. 2007;151(6):737–48.
Henry G, Williamson D, Tampi RR. Efficacy and tolerability of antidepressants in the treatment of behavioral and psychological symptoms of dementia, a literature review of evidence. Am J Alzheimers Dis Other Dement. 2011;26(3):169–83.
Kheirbek RE, Fokar A, Little JT, et al. Association between antipsychotics and all-cause mortality among community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2019;74(12):1916–21.
Koola MM, Varghese SP, Fawcett JA. High-dose prazosin for the treatment of post-traumatic stress disorder. Ther Adv Psychopharmacol. 2014;4(1):43–7.
Kumar S, Kodela S, Detweiler JG, et al. Bupropion-induced psychosis: folklore or a fact? A systematic review of the literature. Gen Hosp Psychiatry. 2011;33(6):612–7.
Kurdyak PA, Juurlink DN, Kopp A, Herrmann N, Mamdani MM. Antidepressants, warfarin, and the risk of hemorrhage. J Clin Psychopharmacol. 2005;25(6):561–4.
Laliberté V, Yu C, Rej S. Acute renal and neurotoxicity in older lithium users: how can we manage and prevent these events in patients with late-life mood disorders? J Psychiatry Neurosci. 2015;40(4):E29–30.
McCrae CS, Ross A, Stripling A, Dautovich ND. Eszopiclone for late-life insomnia. Clin Interv Aging. 2007;2(3):313–26.
Patel K, Allen S, Haque MN, et al. Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant. Ther Adv Psychopharmacol. 2016;6(2):99–144.
Preskorn SH. A way of conceptualizing benzodiazepines to guide clinical use. J Psychiatr Pract. 2015;21(6):436–41.
Richa S, Yazbek JC. Ocular adverse effects of common psychotropic agents: a review. CNS Drugs. 2010;24(6):501–26.
Salem H, Nagpal C, Pigott T, Teixeira AL. Revisiting antipsychotic-induced akathisia: current issues and prospective challenges. Curr Neuropharmacol. 2017;15(5):789–98.
Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry. 2010;71(10):1259–72.
Sommer BR, Fenn HH. Review of topiramate for the treatment of epilepsy in elderly patients. Clin Interv Aging. 2010;5:89–99.
Sommer BR, Fenn H, Pompei P, et al. Safety of antidepressants in the elderly. Expert Opin Drug Saf. 2003;2(4):367–83.
Tambasco N, Romoli M, Calabresi P. Levodopa in Parkinson's disease: current status and future developments. Curr Neuropharmacol. 2018;16(8):1239–52.
Tampi RR, Tampi DJ, Balachandran S, et al. Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses. Ther Adv Chronic Dis. 2016;7(5):229–45.
Teles JS, Fukuda EY, Feder D. Warfarin: pharmacological profile and drug interactions with antidepressants. Einstein (Sao Paulo). 2012;10(1):110–5.
Tisdale JE. Drug-induced QT interval prolongation and torsades de pointes: role of the pharmacist in risk assessment, prevention and management. Can Pharm J (Ott). 2016;149(3):139–52.
Tsuda Y, Saruwatari J, Yasui-Furukori N. Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine. BMJ Open. 2014;4(3):e004216.
Ware MR, Feller DB, Hall KL. Neuroleptic malignant syndrome: diagnosis and management. Prim Care Companion CNS Disord. 2018;20(1):pii: 17r02185.
Williams AM, Park SH. Seizure associated with clozapine: incidence, etiology, and management. CNS Drugs. 2015;29(2):101–11.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Cannon, K. (2021). Adverse Effects of Drugs. In: Tampi, R., Tampi, D., Young, J., Hoq, R., Resnick, K. (eds) Absolute Geriatric Psychiatry Review. Springer, Cham. https://doi.org/10.1007/978-3-030-58663-8_34
Download citation
DOI: https://doi.org/10.1007/978-3-030-58663-8_34
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-58662-1
Online ISBN: 978-3-030-58663-8
eBook Packages: MedicineMedicine (R0)